Establishes the clinical trial access and education fund to provide grants to eligible applicants to provide certain services for patients with life-threatening or disabling conditions or diseases.
Allow individualized investigative treatments for patients with life-threatening or debilitating diseases or conditions.
An Act Concerning Health Insurance Coverage For Routine Patient Care Costs For Certain Clinical Trial Patients.
Relating to authorizing patients with certain terminal conditions to access certain investigational drugs, biological products, and devices that are in clinical trials.
Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.
Relating to access to certain investigational drugs, biological products, and devices that are in clinical trials by patients with severe chronic diseases.
Relating to access to certain investigational drugs, biological products, and devices that are in clinical trials by patients with severe chronic diseases.
Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.
An Act Prohibiting Health Carriers From Requiring The Use Of Step Therapy For Drugs Prescribed To Treat Disabling, Chronic Or Life-threatening Diseases Or Conditions.
An Act Prohibiting Health Carriers From Requiring The Use Of Step Therapy For Drugs Prescribed To Treat Disabling, Chronic Or Life-threatening Diseases Or Conditions.